Veil of Secrecy to Lift on Drug Tests ; Firms Are under Pressure to Release Results of All Their Clinical Trials, Including the Negative Ones. the Result Could Be a New Level of Industry Openness

Gregory M. Lamb writer of The Christian Science Monitor, The Christian Science Monitor

Growing concerns over the safety and efficacy of anti- depressant drugs prescribed to children have caught the eye of Congress and the New York state attorney general. Now they're becoming the catalyst for calls to reform the way clinical trials of all drugs are reported.

Pressure is already causing some changes within the pharmaceutical industry. And it has put the US Food and Drug Administration (FDA), which approves new drugs, in the hot seat. If reforms are carried out, they could bring an unprecedented level of transparency to drug research.

The solution now under consideration: a public database, or registry, of drug trials, where companies would post the …

Questia, a part of Gale, Cengage Learning. www.questia.com
Publication information: Article title: Veil of Secrecy to Lift on Drug Tests ; Firms Are under Pressure to Release Results of All Their Clinical Trials, Including the Negative Ones. the Result Could Be a New Level of Industry Openness. Contributors: Gregory M. Lamb writer of The Christian Science Monitor - Author. Newspaper title: The Christian Science Monitor. Publication date: September 13, 2004. Page number: 11. © 2009 The Christian Science Publishing Society. Provided by ProQuest LLC. All Rights Reserved.

This material is protected by copyright and, with the exception of fair use, may not be further copied, distributed or transmitted in any form or by any means.